Use of c-kit inhibitors for treating plasmodium related...

A - Human Necessities – 61 – P

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61P 33/06 (2006.01) A61K 31/45 (2006.01)

Patent

CA 2564570

The present invention relates to a method for treating plasmodium related diseases comprising administering a compound capable of inhibiting tyrosine kinases, to a human in need of such treatment. Such compounds can be chosen from tyrosine kinase inhibitors including c-kit inhibitors and more particularly non-toxic, selective and potent tyrosine kinases inhibitors. Preferably, said inhibitor is unable to promote death of IL-3 dependent cells cultured in presence of IL-3.

La présente invention porte sur une méthode de prévention ou de traitement de maladies imputables au plasmodium, cette méthode consistant à administrer un composé capable d'inhiber des tyrosine kinases. Ces composés peuvent être choisis à partir des inhibiteurs de la tyrosine kinase comprenant des inhibiteurs de c-kit et, plus particulièrement, à partir d'inhibiteurs des tyrosine kinases non toxiques, sélectifs et puissants. De préférence, cet inhibiteur est capable de favoriser la mort des cellules dépendant d'IL-3 et mises en culture en présence d'IL-3.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of c-kit inhibitors for treating plasmodium related... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of c-kit inhibitors for treating plasmodium related..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of c-kit inhibitors for treating plasmodium related... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1841817

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.